Bearish flow noted in Novo Nordisk (NVO) with 7,917 puts trading, or 1.2x expected. Most active are 3/14 weekly 76 puts and Sep-25 110 puts, ...
Novo Nordisk (NYSE: NVO) shareholders know all ... Unfortunately, shares of the company behind Ozempic have been trading about 39% below last year's peak. Now that it's been beaten down, ...
Novo Nordisk said on Wednesday it would begin selling ... US-listed shares of Novo were up 4.2% to $91.16 in morning trading. Compounding pharmacies that have been selling hundreds of ...
Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...
Hims stock stood about 22% lower in recent trading. Novo Nordisk shares jumped as much as 4% in Denmark. Hims will stop offering mass compounding of semaglutide after the first quarter ...
Novo Nordisk A/S's CagriSema faces challenges, yet new trials aim to enhance efficacy, rival Eli Lilly in obesity treatments, ...
The stock is currently trading above its 50-day moving average but below its 200-day moving average. Several factors in the past three months caused Novo Nordisk's stock to dip. In December 2024 ...